Work

Small popliteal aneurysm thrombosis after SARS-CoV-2 vaccination

Year: 2022

Type: article

Abstract: The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic cannot be overstated. So far, more than 5 million people have succumbed. The virus essentially held the world hostage until effective vaccines were developed and released. Although generally safe, novel therapies are not devoid of risk. For instance, venous thromboembolic complications of SARS-CoV-2 vaccine have been widely documented.1 This letter narrates the rare case of peripheral arterial thrombosis after coronavirus disease 2019 immunization.

Source: Journal of Vascular Surgery Cases and Innovative Techniques

DOI: 10.1016/j.jvscit.2022.04.004

Authors: Rym El Khoury, Vikram Tammana, Jill Patton, Chad E. Jacobs, John V. White, Lewis B. Schwartz

Institutions: University of California, San Francisco, University of Illinois Chicago, Advocate Lutheran General Hospital

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $550